Watch the video and possibly save your life or others in an emergency
The COVID pandemic showed us all just how fragile America’s supply chain can be. So, what will happen if there’s another — possibly an even worse — breakdown? And more specifically, what will happen to our medicine supplies? It’s something JASE Medical’s Founder and CEO, Dr. Shawn Rowland, thinks about often: ‘I could sit here for three hours and talk about the the razor-knife edge that we’re on’ with potential supply chain issues, he tells Glenn. So, in this clip, Dr. Rowland describes one solution to medicine shortages recently devised by his team — and it’s a solution that potentially could save your life… Continued Below The Video
A cadre of experts from Johns Hopkins University recently engaged in a discussion around the pervasive issue of shortages in chemotherapy drugs, antibiotics, and other vital medicines, as well as potential solutions to overcome this crisis. Healthcare providers and institutions nationwide are currently faced with the challenge of managing the limited availability of these essential drugs, due to a substantial deficit of medicines required for the treatment of cancer and a host of other conditions.
For the past ten years, the United States has intermittently experienced prescription drug shortages, with the current deficit reaching unprecedented levels. This situation imposes significant challenges on physicians’ decision-making processes and impacts patients who rely on these crucial medications, such as chemotherapy drugs and antibiotics, according to experts from Johns Hopkins. These insights were shared during a recent virtual discussion in the Johns Hopkins Congressional Briefing series.
Get back to that pre-COVID feeling.
Vaccinated or not, toxic spike proteins pose a long-term threat to your health.
This revolutionary Spike Support Formula is the only product that contains nattokinase and dandelion root, researched to block and dissolve spike proteins inside your body. – CLICK HERE or below… 🔥
Dr. Amanda Fader, a distinguished professor of gynecology and obstetrics at Johns Hopkins Medicine, emphasized the crucial role of chemotherapy drugs in oncology, asserting their importance in prolonging and saving the lives of patients. She noted the severity of the situation, stating that “many life-saving drugs that we use to treat both adults and children [with cancer] are the drugs in the most critical shortage at this time.” There is currently a nationwide shortage of 15 commonly prescribed chemotherapy drugs used in the treatment of a range of cancers, from gynecological to esophageal.
The most acute shortages are being experienced in the supply of platinum-based drugs like cisplatin and carboplatin, which often serve as curative treatments for numerous cancer patients. A survey conducted by the National Comprehensive Cancer Network revealed that among 27 cancer centers across the country, 93% reported experiencing a shortage of carboplatin, and 70% reported a similar deficit of cisplatin. These two drugs are often used synergistically to cure various types of cancer.
Dr. Zelenko is the man who advised Trump on Hydroxy ..Here’s his recipe to keep immunity strong and fight off you-know-what… – click here or below
Dr. Robert Carlson, the network’s CEO, expressed deep concern about the situation, highlighting the distressing reports from oncologists and pharmacists nationwide struggling to find suitable alternative treatments for their patients. With platinum-based drugs being prescribed to an estimated 10% to 20% of all cancer patients, the impact of these shortages is far-reaching. Dr. Carlson calls for collective efforts to address the current situation and to prevent a recurrence in the future.
Andy Vermaut shares:Widespread Carboplatin, Cisplatin Shortages: NCCN Survey: A new NCCN survey found that most centers are experiencing shortages of carboplatin and cisplatin. The NCCN has called for strategies to address these drug… Thank you. https://t.co/igxnc84Cet pic.twitter.com/ABykAWqfFS
— Andy Vermaut (@AndyVermaut) June 8, 2023
The survey results showed that 64% of cancer centers were still able to administer carboplatin as per the planned dosage and schedule, and all centers could still administer cisplatin. However, only about 40% of these centers received any information regarding the availability of carboplatin or cisplatin from the manufacturers or suppliers.
Alyssa Schatz, Senior Director of Policy and Advocacy for the National Comprehensive Cancer Network, reiterated the severity of the impact of these shortages and emphasized the need for a unified approach to tackle future drug deficits and ensure the availability of quality cancer care for all.
The issue of drug shortages has become increasingly prominent as the United States grapples with an ongoing crisis. Cancer treatments have been particularly affected, with about two dozen chemotherapy drugs currently in active shortage, ranking fifth in any drug category. Based on data from the University of Utah Drug Information Service, the current shortages are the highest since 2014.
More death and scarcity from the American health care system that always puts profits over people.
“Cancer drug shortages: 14 medicines now in short supply, according to FDA” https://t.co/e27KOZpwVw— Bob Hennelly (@stucknation) June 7, 2023
To mitigate these shortages, the US Food and Drug Administration has recently announced its collaboration with Chinese pharmaceutical company Qilu Pharmaceutical to import cisplatin and boost its supply. Additionally, Canadian pharmaceutical company Apotex will temporarily distribute the injectable medication in 50-milligram vials.
Thousands of #cancer patients across the United States are unable to access life-saving treatments and medicines due to chronic widespread shortages, according to recent data. See – Doctors Forced to Ration Life-Saving Cancer Treatment Drugs Amid Shortages in US – NTD
Drug shortages across the U.S. are putting some patients in limbo as they wait for critical treatments. Carrie Cherkinsky is battling ovarian cancer and says she's "scared" and "nervous" not knowing if she'll get the medicine she needs.
More: https://t.co/HAgMO4y6xQ #OnBalance pic.twitter.com/fHprUseMX7
— NewsNation (@NewsNation) June 1, 2023
Want to know more?
- There has been a rise in pharmacists reporting that medicine shortages have put patients at risk in the past six months, despite government efforts to try and mitigate problems – Pharmaceutical Journal
- The U.S. is now so incapable of making the medicine we need that it’s allowing imports of an *unapproved* cancer drug from China. The shortages stem from the unexpected closure of a factory in India. At least 13 other cancer drugs are in short supply. – CNBC